Focus on Molecular Therapeutics
Below are all the Focus articles related specifically to our Molecular Therapeutics Research Program. All Focus articles are also available.
Cancer cells misbehave by dividing and traveling to places they aren't supposed to go. A cell's DNA (deoxyribonucleic acid) tells it what to do: a standard DNA sequence is well ordered and gives proper instructions. But when DNA is damaged, it can send out wrong information.
November 11, 2013
May 28, 2013
Results from a phase III clinical trial comparing a newer chemotherapy agent called eribulin mesylate with capecitabine, a standard drug used for chemotherapy today in women with previously treated metastatic breast cancer, showed that eribulin demonstrated a trend toward improved overall survival.
January 07, 2013
March 26, 2012
April 15, 2010